UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5501
Bank of Marin Bancorp
BMRC
$459M
| $773K | ﹤0.01% |
32,520
+18,287
| +128% | +$432K |
|
5502
CALL
Fastly Inc
FSLY
$3.66B
| $772K | ﹤0.01% |
81,800
| – | – |
|
5503
Cambria Foreign Shareholder Yield ETF
FYLD
$720M
| $772K | ﹤0.01% |
30,608
-2,646
| -8% | -$69.8K |
|
|
CWEN.A
5504
DELISTED
Clearway Energy Class A
CWEN.A
| $771K | ﹤0.01% |
31,553
+14,081
| +81% | +$365K |
|
|
BLTE
5505
Belite Bio
BLTE
$6.54B
| $770K | ﹤0.01% |
12,207
+12,079
| +9,437% | +$796K |
|
5506
First Mid Bancshares
FMBH
$1.36B
| $769K | ﹤0.01% |
20,890
+4,317
| +26% | +$172K |
|
|
ENFN
5507
DELISTED
Enfusion, Inc.
ENFN
| $768K | ﹤0.01% |
74,565
+16,337
| +28% | +$158K |
|
5508
Global X SuperDividend US ETF
DIV
$783M
| $767K | ﹤0.01% |
42,559
-2,807
| -6% | -$52.2K |
|
5509
Shenandoah Telecom
SHEN
$746M
| $767K | ﹤0.01% |
60,848
+38,590
| +173% | +$519K |
|
|
FAX
5510
abrdn Asia-Pacific Income Fund
FAX
$600M
| $766K | ﹤0.01% |
52,052
-8,699
| -14% | -$141K |
|
5511
ProShares UltraShort Bloomberg Natural Gas
KOLD
$107M
| $766K | ﹤0.01% |
+17,925
| New | +$1.16M |
|
5512
Genie Energy
GNE
$383M
| $765K | ﹤0.01% |
49,092
+38,332
| +356% | +$601K |
|
5513
PUT
Allegro MicroSystems
ALGM
$8.16B
| $765K | ﹤0.01% |
35,000
| – | – |
|
5514
Loar Holdings
LOAR
$6.64B
| $765K | ﹤0.01% |
10,349
+9,210
| +809% | +$755K |
|
5515
Universal Logistics Holdings
ULH
$529M
| $763K | ﹤0.01% |
16,618
+10,254
| +161% | +$478K |
|
5516
Ispire Technology
ISPR
$98.2M
| $763K | ﹤0.01% |
151,633
+141,642
| +1,418% | +$868K |
|
5517
Companhia Siderúrgica Nacional
SID
$1.23B
| $762K | ﹤0.01% |
528,948
+440,576
| +499% | +$863K |
|
5518
Hycroft Mining Holding Corp
HYMC
$2.47B
| $761K | ﹤0.01% |
344,302
+336,338
| +4,223% | +$796K |
|
5519
Kyverna Therapeutics
KYTX
$484M
| $761K | ﹤0.01% |
203,403
+195,207
| +2,382% | +$935K |
|
5520
Fidelity Corporate Bond ETF
FCOR
$353M
| $757K | ﹤0.01% |
16,330
+117
| +0.7% | +$5.52K |
|
5521
Orion Group Holdings
ORN
$418M
| $756K | ﹤0.01% |
103,194
+82,733
| +404% | +$598K |
|
5522
NVE Corp
NVEC
$609M
| $755K | ﹤0.01% |
9,273
+6,237
| +205% | +$489K |
|
5523
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $751K | ﹤0.01% |
12,050
+4,790
| +66% | +$313K |
|
5524
PUT
VF Corp
VFC
$5.89B
| $751K | ﹤0.01% |
+35,000
| New | +$713K |
|
5525
Lennar Class B
LEN.B
$20.8B
| $751K | ﹤0.01% |
5,975
+1,877
| +46% | +$282K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.